Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 197

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

N-Terminal Probrain Natriuretic Peptide (NT-proBNP) in the Emergency Diagnosis and In-Hospital Monitoring of Patients with Dyspnoea and Ventricular Dysfunction

Open access
Bayés-Genís, Antoni, Santaló-Bel, Miquel, Zapico-Muñiz, Edgar, López, Laura, Cotes, Carlos, Bellido, Jesús, Leta, Rubén, Casan, Pere, Ordóñez-Llanos, Jordi·2004·European Journal of Heart Failure

Abstract

Objective: To evaluate the utility of NT-proBNP in the emergency diagnosis and in-hospital monitoring of patients with acute dyspnoea and ventricular dysfunction. Background: Misdiagnosis of heart failure (HF) is common in the urgent care setting using clinical diagnostic tests. Reports show that BNP is useful to diagnose HF in patients with acute dyspnoea. Methods: Prospective study of 100 patients attending the Emergency Department (ED) for acute dyspnoea. Final diagnosis was determined on the basis of ED data sheets, echocardiography and pulmonary function tests. NT-proBNP levels were obtained on admission, at 24 h and at day 7. Results: Patients with ventricular dysfunction were sub-classified into decompensated HF and masked HF, defined as HF with concomitant signs of pulmonary disease. Decompensated and masked HF patients had significantly higher NT-proBNP values than patients with non-cardiac dyspnoea (normal ventricular function) (920±140 and 978±363 vs. 50±15 pmol/L; P<0.001 and P<0.01, respectively). The mean area under the ROC curve for NT-proBNP was 0.957 (95% CI, 0.918 to 0.996, P<0.001). In multiple logistic-regression analysis NT-proBNP>115 pmol/l was the strongest independent predictor of ventricular dysfunction (odds ratio 45.4; 95% CI: 4.5–452.3). At day 7, a significant and similar reduction in NT-proBNP was observed in the two groups of patients with ventricular dysfunction (P<0.001 vs. admission values), but complete clinical resolution was less frequent in masked HF patients (P<0.05 vs. decompensated HF). Conclusions: NT-proBNP is a new candidate marker for the detection and exclusion of ventricular dysfunction in patients attending the ED for acute dyspnoea. NT-proBNP may also serve to monitor outcome during hospitalization.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejheart.2003.12.013

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 197

Metadata

Authors
Bayés-Genís, A., Santaló-Bel, M., Zapico-Muñiz, E., López, L., Cotes, C., Bellido, J., Leta, R., Casan, P., & Ordóñez-Llanos, J.
Venue
European Journal of Heart Failure
Published
2004-03-01
Volume
6
Issue
3
Pages
301-308
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2074559673
Cited by
197
References
1
FWCI
13.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: N-Terminal Probrain Natriuretic Peptide (NT-proBNP) in the Emergency Diagnosis and In-Hospital Monitoring of Patients with Dyspnoea and Ventricular Dysfunction. https://app.cochat.ai/papers/10.1016/j.ejheart.2003.12.013
The paper
Bayés-Genís, A., Santaló-Bel, M., Zapico-Muñiz, E., López, L., Cotes, C., Bellido, J., Leta, R., Casan, P., & Ordóñez-Llanos, J. (2004). N-Terminal Probrain Natriuretic Peptide (NT-proBNP) in the Emergency Diagnosis and In-Hospital Monitoring of Patients with Dyspnoea and Ventricular Dysfunction. European Journal of Heart Failure. https://doi.org/10.1016/j.ejheart.2003.12.013

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.